You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
A multiparticulate delayed-release platform for oral delivery of a novel ghrelin agonist peptide to rodents: formulation design and in vitro characterization.
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-B-019-Tuesday
- By: HOWICK, Ken (University College Cork, Pharmacy, Cork, Ireland)
- Co-author(s): Ken Howick: School of Pharmacy, University College Cork, Cork, Ireland;Anatomy & Neuroscience, University College Cork, Cork, Ireland;Food for Health Ireland, University College Cork, Cork, Ireland
Harriët Schellekens: Anatomy & Neuroscience, University College Cork, Cork, Ireland;APC Microbiome Institute, University College Cork, Cork, Ireland;Food for Health Ireland, University College Cork, Cork, Ireland
John F Cryan: Anatomy & Neuroscience, University College Cork, Cork, Ireland;APC Microbiome Institute, University College Cork, Cork, Ireland
Brendan T Griffin: School of Pharmacy, University College Cork, Cork, Ireland;Food for Health Ireland, University College Cork, Cork, Ireland - Abstract:
Backgrounds
Ghrelin is an orexigenic peptide which has received considerable focus in treating appetite disorders. Dysregulation of the ghrelin axis is a factor in age- and disease-related cachexia. We have identified dairy-derived peptide hydrolysates with ghrelin receptor (GHSR-1a) agonist activity.Aims
To design an oral delivery platform to.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026